Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Valuation ...

If they generate the levels of cash you reference in that post, considering their workforce/overhead, look for them to possibly become an acquisition target.

I'm hoping Turley has better plans for the revenues than dividend distribution.

Share
New Message
Please login to post a reply